Crossmark

Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy—a guidance by the GoCART Coalition Pharmacist Working Group

Crossref DOI link: https://doi.org/10.1038/s41409-023-02072-7

Published Online: 2023-08-01

Published Print: 2023-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nezvalova-Henriksen, Katerina http://orcid.org/0000-0002-8085-4932
Langebrake, Claudia

Bauters, Tiene

Moreno-Martinez, Maria-Estela http://orcid.org/0000-0001-6752-873X
Ahnfelt, Emelie

Ekelund, Heidi

Domingos, Vera

Pires, Vera

Bonnin, Agnes

Bojanić, Ines

Cabrerizo, Yolanda

Terwel, Sofie

Tam, Alice
License Information

Text and Data Mining valid from 2023-08-01

Version of Record valid from 2023-08-01
More Information

Article History

Received: 17 January 2023

Revised: 29 June 2023

Accepted: 24 July 2023

First Online: 1 August 2023

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below